NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,160 filers reported holding NOVARTIS A G in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $2,456 | -2.4% | 24,326 | -1.5% | 1.17% | -9.3% |
Q3 2023 | $2,516 | +0.3% | 24,696 | -0.6% | 1.29% | +6.1% |
Q2 2023 | $2,508 | +8.2% | 24,856 | -1.4% | 1.22% | +3.2% |
Q1 2023 | $2,319 | +0.5% | 25,211 | -0.9% | 1.18% | -2.1% |
Q4 2022 | $2,307 | -99.9% | 25,433 | -3.4% | 1.21% | +11.6% |
Q3 2022 | $2,001,000 | -10.8% | 26,332 | -0.8% | 1.08% | -2.9% |
Q2 2022 | $2,244,000 | – | 26,543 | – | 1.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |